US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...
China's advancements in disruptive technologies are rapidly blurring the lines between science fiction and reality, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback